Pharmaceutical

Eli Lilly to invest $4.5bn for drug manufacturing and trial medicine production

Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing medicines for clinical trials.

Oct 4, 2024 - 04:00
Eli Lilly to invest $4.5bn for drug manufacturing and trial medicine production
Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing medicines for clinical trials.
Read the original article

Tags:

Previous Article

Gilead signs agreements to facilitate access to HIV prevention drug

Next Article

Social media algorithms are driving the GLP-1 drugs boom

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Sarepta’s Elevidys secures US label expansion for DMD

Sarepta’s Elevidys secures US label expansion for DMD

Jun 22, 2024

STAT+: 6 ways the government could help address drug shortages, including in cancer

STAT+: 6 ways the government could help address drug sh...

Sep 28, 2023

How regenerative medicine M&A performed in the pharmace...

Jul 31, 2023